PYC Equity Raising to Raise up to $55 Million
Filed with ASX ·
6ix hasn’t read this filing yet.
PYC Therapeutics Limited on 6ix
Earlier from PYC Therapeutics
- New Drug for Substantial Unmet Need Added to Pipeline
- PYCs Lead Drug Effective in Patient Derived Models Tested
- Second Potential Blockbuster Drug Added to PYCs Pipeline
- Creation of Novel Gene Therapy Delivery Technology
- Appendix 4E Preliminary Final Report
Later from PYC Therapeutics
- PYC Business and Equity Raising Presentation
- Successful Institutional Entitlement Offer and Placement
- Review of Activities and Appendix 4C
- Visual Evidence of Lead Drugs Efficacy
- Quarterly Activities Report and Appendix 4C
Follow PYC Therapeutics into a list and get an email when it puts out news.
Follow PYC Therapeutics